PT-141
PT-141, also known as Bremelanotide, is a melanocortin receptor agonist that works through the central nervous system to stimulate sexual desire directly in the brain. Unlike treatments that only address blood flow, PT-141 targets the neurological pathway behind arousal itself, making it effective for both men and women across a wide range of sexual health concerns including low libido, reduced arousal, and difficulty with desire that does not respond to hormonal or vascular treatments alone.
What is PT-141?
PT-141 is a synthetic peptide that activates melanocortin receptors in the brain, specifically targeting the pathways involved in sexual arousal and desire.
Originally developed from the tanning peptide Melanotan II, PT-141 was found to have significant effects on sexual function independent of its melanogenic properties.
This treatment represents a fundamentally different approach to sexual wellness, working through the central nervous system rather than the vascular system.
What are the benefits?
PT-141 can help restore natural sexual desire and improve arousal response in both men and women experiencing decreased libido.
Many patients report improved confidence and relationship satisfaction as a result of treatment.
The peptide works regardless of the underlying cause of decreased desire, making it versatile for various presentations of sexual dysfunction.